XML 16 R12.htm IDEA: XBRL DOCUMENT v2.3.0.15
Derivative Financial Instruments
9 Months Ended
Sep. 30, 2011
Derivative Financial Instruments: [Abstract] 
Derivative Financial Instruments:
6. Derivative Financial Instruments:

The Company generally does not use derivative instruments to hedge exposures to cash-flow risks or market-risks that may affect the fair values of its financial instruments. However, certain other financial instruments, such as warrants and embedded conversion features that are indexed to the Company's Common Stock, are classified as liabilities when either: (a) the holder possesses rights to net-cash settlement or (b) physical or net-share settlement is not within the control of the Company. In such instances, net-cash settlement is assumed for financial accounting and reporting, even when the terms of the underlying contracts do not provide for net-cash settlement. Such financial instruments are initially recorded at fair value estimated on the settlement date using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate, and then adjusted to fair value at the close of each reporting period.

The following tabular presentation reflects the components of derivative assets and liabilities as of September 30, 2011 and December 31, 2010:

 

                 
     September 30,
2011
     December 31,
2010
 

Derivative asset at fair value:

                 

Free standing warrants related party

   $ 466,140       $ 1,299,031   
    

 

 

    

 

 

 
     
     September 30,
2011
     December 31,
2010
 

Shares into which derivative asset can be settled:

                 

Free standing warrants related party

     2,000,000         2,000,000   
    

 

 

    

 

 

 
     
     September 30,
2011
     December 31,
2010
 

Derivative liability at fair value:

                 

Free standing warrants*

   $ 788,249       $ 4,989,993   
    

 

 

    

 

 

 

 

* These warrants can be settled by issuance of 3,246,301 and 4,322,421 shares of Common stock at September 30, 2011 and December 31, 2010, respectively.

The following tabular presentation reflects the components of the gain (loss) of derivative financial instruments for the three and nine month periods ended September 30, 2011 and 2010:

 

                                 
     3 months
ending
September30,
2011
    3 months
ending
September30,
2010
    9 months
ending
September30,
2011
    9 months
ending
September30,
2010
 

Derivative gain (loss) in the accompanying statement of operations is related to the individual derivatives as follows:

                                

Free standing warrants assets, related party

   $ (124,400   $ (415,400   $ (832,891   $ 822,800   

Free standing warrants liabilities

     2,596,950        (695,133     3,864,997        4,243,109   
    

 

 

   

 

 

   

 

 

   

 

 

 
     $ 2,472,550      $ (1,110,533   $ 3,032,106      $ 5,065,909